Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy

Treatment of multi-drug resistant Tuberculosis (MDR-TB) is challenging because it mostly relies on drugs with lower efficacy and greater toxicity than those used for drug-susceptible TB. Aim of the study was to describe the frequency and type of adverse drug reactions in a cohort of MDR-TB patients...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:PloS one Ročník 14; číslo 2; s. e0212948
Hlavní autori: Gualano, Gina, Mencarini, Paola, Musso, Maria, Mosti, Silvia, Santangelo, Laura, Murachelli, Silvia, Cannas, Angela, Di Caro, Antonino, Navarra, Assunta, Goletti, Delia, Girardi, Enrico, Palmieri, Fabrizio
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Public Library of Science 28.02.2019
Public Library of Science (PLoS)
Predmet:
ISSN:1932-6203, 1932-6203
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Buďte prvý, kto okomentuje tento záznam!
Najprv sa musíte prihlásiť.